Barry, OppHub America Desk · · Source: yahoo-tickers-tape-movers
Abbott Laboratories Posts 13% Sales Growth, Outpacing Intuitive Surgical
Investors seeking consistent growth in healthcare may consider Abbott Laboratories (:ABT) given its robust 13% reported sales increase.,Traders might watch Intuitive Surgical (N:ISRG) for short-term price movements, observing its 4.8% comparable sales growth against its premium valuation.
Based on reporting from yahoo-tickers-tape-movers.
Abbott Laboratories (NYSE:ABT) reported a 13% sales increase for fiscal Q2 2026, driven by strong demand in diagnostics and medical devices. This performance contrasts with Intuitive Surgical (NASDAQ:ISRG), which saw comparable sales grow 4.8%. Abbott's results may suggest resilient growth in established healthcare sectors.
Market context for this story
As of: After HoursLoading quotes…
Informational only — not investment advice. Full markets →
$ABTAbbott Laboratories
TradingView
Live chart & market data via TradingView · OppHub classroom · Delayed or exchange real-time per TradingView data agreements · Not investment advice
Educational TradingView chart — search any symbol in the widget. Confirm on /markets/ABT and related $ISRG, $INTU. Not investment advice.
Related markets
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).
Abbott Laboratories (NYSE:ABT) posted robust fiscal second-quarter results, with reported sales climbing 13% and comparable sales up 4.8%. This growth was fueled by solid performance in its cancer diagnostics and medical devices segments. In comparison, Intuitive Surgical (NASDAQ:ISRG) registered comparable sales growth of 4.8% during the same period.
### Money Play Investors looking for established healthcare exposure may favor Abbott Laboratories (NYSE:ABT) due to its consistent reported sales growth, while traders might monitor Intuitive Surgical (NASDAQ:ISRG) for potential short-term opportunities driven by its premium valuation.
## Catalyst Analysis: Sales Growth Comparison Abbott Laboratories' reported sales rose 13% for the quarter, a figure that significantly outpaced the 4.8% comparable sales growth reported by Intuitive Surgical. This divergence highlights differing growth trajectories within the medical technology sector, with Abbott demonstrating broad-based strength across its product lines.
The performance of Abbott's diagnostics and medical device divisions suggests sustained demand from healthcare providers and patients alike. Investors will be assessing whether Abbott can maintain this elevated growth rate, particularly in light of its decision to raise its annual profit forecast, though specific forecast details were not provided.
## $ABT+WL Technical Analysis & Key Risk Watch Key levels for $ABT+WL (educational): R2 $112.47 · R1 $111.28 · last $111.25 · S1 $110.79 · S2 $107.36.
## $ISRG+WL Technical Analysis & Key Risk Watch
### Sector Ripple / Impact on Health Care The contrasting growth rates between Abbott and Intuitive Surgical may lead investors to re-evaluate sector allocations. Companies like Abbott, demonstrating consistent reported growth, could be favored in a risk-aware environment. Other medical device and diagnostics firms will be watched for similar performance trends.
$INTU+WL: last $325.25 (+1.04% day); SMA50 $291.87; SMA200 $458.66; RSI14 65.2.
Read the full story
Original reporting and related coverage — attribution links only, not paid recommendations.
Trade this story
Robinhood
Webull
Tradier
IBKR
Chart this story
TradingView
Broker and exchange buttons use invite / refer-a-friend links (rewards may be capped). Charting links (TradingView) are partner offers that may pay OppHub America a commission at no extra cost to you.
OppSHOP
Full OppSHOP →As an Amazon Associate, OppHub America earns from qualifying purchases. Shopping here helps keep the site free — at no extra cost to you. Disclosure
OppSHOP
Related to this story
Investors seeking consistent growth in healthcare may consider Abbott La
Shop related →
Investing books
Read the classics
Shop this pick →
Personal finance books
Run the household books
Shop this pick →
Trading notebooks
Write the thesis first
Shop this pick →
Monitor for charts
See every pane
Shop this pick →
Story playbook
A pre-built map of what to watch — stocks, ETFs, and educational next steps. Not personalized advice.
Snapshot date: August 19, 2026 at 9:26 PM ET
This playbook was built when the story published and is not live-updated. Prices, news, and risk can change after this date — treat it as a starting map, not a current trade ticket.
Story → money map
medical technology growth
Abbott Laboratories had a great quarter with sales up 13%, beating rival Intuitive Surgical. People care because it shows which big medical companies are growing the fastest.
What changed
Abbott Laboratories posted a 13% sales increase, outpacing Intuitive Surgical's 4.8% comparable growth.
Who wins / who loses
Abbott Laboratories benefits from strong diagnostic demand, while high-valuation peers like Intuitive Surgical face heightened scrutiny.
Time horizon
Think in terms of the next few months.
Confidence & best fit
medium confidence · Long-term investor, Active trader
Safer theme exposure (ETFs)
Baskets that own the theme without betting on one company.
Single stocks (higher risk)
Primary = closest to the story · Peers = same industry · Second-order = knock-on effects · Avoid = looks related but may be a trap
Primary
- $ABTBuild slowly — only if it fits your plan
Abbott is growing fast and making more money, which usually attracts long-term investors.
View $ABT chart → · End-of-day delayed data
Peer
- $ISRGWatch — track, don’t rush
Intuitive Surgical is growing slower, so traders are watching to see if its high stock price drops.
View $ISRG chart → · End-of-day delayed data
- $JNJWatch — track, don’t rush
A giant healthcare rival used as a baseline for comparison.
View $JNJ chart → · End-of-day delayed data
Second-order
- $MDTWatch — track, don’t rush
Other big medical device companies might move up or down based on Abbott's success.
View $MDT chart → · End-of-day delayed data
Options (education only)
No strikes or expiries — a framework for how traders might express the view. Options can expire worthless.
Direction: bullish · Style: Covered-call income (only if you already own shares) · Level: intermediate
Like renting out part of your stock ownership for extra cash. Beginners should skip this until comfortable owning the stock.
Income / OppHub America angle
Not a trade tip — ways to use the insight outside the market.
- Research regional healthcare providers experiencing high demand for diagnostic testing equipment.
What would break this thesis
- Abbott failing to meet its raised annual profit forecast in subsequent quarters.
- A broader macroeconomic downturn impacting elective medical procedures.
What to do next on OppHub America
Saved playbooks stay on this device for now.
Important
Not financial advice. OppHub America playbooks are educational market maps only — not recommendations to buy, sell, or hold any security. Markets move fast; information can be wrong or outdated. Trade and invest at your own risk. Do your own research or consult a licensed advisor.
Based on reporting from yahoo-tickers-tape-movers.
Informational and educational only — not investment, financial, or legal advice. Disclosure
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).